Notably, SI was also found to be significantly higher for both spike (p = 0.0007) and non-spike (p = 0.0054) MPs in response to this (OX40+CD40L+) AIM panel in severe COVID-19 patients compared to the unexposed participants (Figure 4A). Here, CD40LG is linked to COVID-19.